Trials Sponsors Conditions Drugs Pricing

Conditions

Prostate Hyperplasia Urinary Bladder Neoplasms

Outcome Measures

Primary Outcomes (1)

Serum concentrations of sexual steroids and intra-tissue on healthy prostates
A bio-informatical analysis will be performed to compare steroids concentrations profiles in both arms.
30 minutes

Study Arms (2)

Bladder cancer

EXPERIMENTAL

▪ Patients justifying prostatectomy together with the bladder (radical cystectomy for bladder cancer).

Biological: steroids concentrations determination

benign prostate hyperplasia

OTHER

▪ Patients with benign prostate hyperplasia who justified a prostatectomy.

Biological: steroids concentrations determination

Interventions

steroids concentrations determinationBiological

Bladder cancerbenign prostate hyperplasia

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexmale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Men aged over 18 years
Surgical indication justifying protatique prostatectomy, or complete prostatocystectomie, or removal of a metastasis of prostate cancer.

Sponsors & Collaborators

Hopital Foch
Otherlead

Study Sites (1)

Hopital Foch

Suresnes, 92150, France

MeSH Terms

Conditions

Urinary Bladder NeoplasmsProstatic Hyperplasia

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital DiseasesProstatic DiseasesGenital Diseases, MaleGenital Diseases

Study Officials

Henry Botto, PhD
Urologie Hopital Foch
PRINCIPAL INVESTIGATOR

Enrollment

107 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: PREVENTION
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

May 12, 2016

First Posted

May 19, 2016

Study Start

September 2014

Actual (reported)

Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Bladder cancer

benign prostate hyperplasia

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Bladder cancer

benign prostate hyperplasia

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations